Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Willner & Heller LLC

Willner & Heller LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,655 shares of the medical equipment provider’s stock after selling 220 shares during the period. Intuitive Surgical makes up about 1.7% of Willner & Heller LLC’s portfolio, making the stock its 11th biggest position. Willner & Heller LLC’s holdings in Intuitive Surgical were worth $1,908,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Godsey & Gibb Inc. grew its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at about $36,000. Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the third quarter worth about $38,000. Finally, DT Investment Partners LLC lifted its position in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 2,128 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock worth $25,012,927. Corporate insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Mizuho upped their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Truist Financial raised their target price on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Up 1.5 %

Shares of Intuitive Surgical stock opened at $592.64 on Monday. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $597.68. The stock has a market cap of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The business has a fifty day simple moving average of $540.66 and a 200 day simple moving average of $499.19.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.